171
Views
15
CrossRef citations to date
0
Altmetric
Perspectives

Potential Role of Nrf2 Activators with Dual Antiviral and Anti-Inflammatory Properties in the Management of Viral Pneumonia

&
Pages 1735-1741 | Published online: 11 Jun 2020

References

  • Li G, DeClercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149–150. doi:10.1038/d41573-020-00016-032127666
  • Wen CC, Kuo YH, Jan JT, et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem. 2007;50(17):4087–4095. doi:10.1021/jm070295s17663539
  • Liu Q, Gao Y, Ci X. Role of Nrf2 and its activators in respiratory diseases. Oxid Med Cell Longev. 2019;2019. doi:10.1155/2019/7090534.
  • Robledinos-Antón N, Fernández-Ginés R, Manda G, Cuadrado A. Activators and inhibitors of NRF2: A review of their potential for clinical development. Oxid Med Cell Longev. 2019;2019. doi:10.1155/2019/9372182.
  • Chen TY, Chen DY, Wen HW, et al. Inhibition of enveloped viruses infectivity by curcumin. PLoS One. 2013;8(5):1–11. doi:10.1371/journal.pone.0062482
  • Zorofchian Moghadamtousi S, Abdul Kadir H, Hassandarvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014;2014. doi:10.1155/2014/186864.
  • Praditya D, Kirchhoff L, Brüning J, Rachmawati H, Steinmann J, Steinmann E. Anti-infective properties of the golden spice curcumin. Front Microbiol. 2019;10(MAY). doi:10.3389/fmicb.2019.00912
  • Avasarala S, Zhang F, Liu G, Wang R, London SD, London L. Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome. PLoS One. 2013;8(2):1–13. doi:10.1371/journal.pone.0057285
  • Xu Y, Liu L. Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway. Influenza Other Respi Viruses. 2017;11(5):457–463. doi:10.1111/irv.12459
  • Dai J, Gu L, Su Y, et al. Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-κB pathways. Int Immunopharmacol. 2018;54(November 2017):177–187. doi:10.1016/j.intimp.2017.11.00929153953
  • Han S, Xu J, Guo X, Huang M. Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production. Clin Exp Pharmacol Physiol. 2018;45(1):84–93. doi:10.1111/1440-1681.1284828853207
  • XuY H, Dong J-H, AnW M, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect. 2020;80(4):394–400. doi:10.1016/j.jinf.2020.02.01732109443
  • Lin X P, Xue C, Zhang J M, Wu W J, Chen X Y, Zeng Y M. Curcumin inhibits lipopolysaccharide-induced mucin 5AC hypersecretion and airway inflammation via nuclear factor erythroid 2-related factor 2. Chin Med J. 2018;131(14):1686–1693. doi:10.4103/0366-6999.23586329998888
  • Shelton LM, Park BK, CoppleI M. Role of Nrf2 in protection against acute kidney injury. Kidney Int. 2013;84(6):1090–1095. doi:10.1038/ki.2013.24823783243
  • Zuccotti GV, Trabattoni D, Morelli M, Borgonovo S, Schneider L, Clerici M. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections. J Biol Regul Homeost Agents. 2009;23(2):119–123.19589293
  • Jamwal R. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. J Integr Med. 2018;16(6):367–374. doi:10.1016/j.joim.2018.07.00130006023
  • Hu Y, Li M, Zhang M, Jin Y. Inhalation treatment of idiopathic pulmonary fibrosis with curcumin large porous microparticles. Int J Pharm. 2018;551(1–2):212–222. doi:10.1016/j.ijpharm.2018.09.03130227240
  • Bolger GT, Licollari A, Tan A, et al. Pharmacokinetics of liposomal curcumin (LipocurcTM) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. Cancer Chemother Pharmacol. 2019;83(2):265–275. doi:10.1007/s00280-018-3730-530430227
  • Lasoff DR, Cantrell FL, Ly BT. Death associated with intravenous turmeric (Curcumin) preparation. Clin Toxicol. 2018;56(5):384–385. doi:10.1080/15563650.2017.1388387
  • Rothan HA, Zhong Y, Sanborn MA, et al. Small molecule grp94 inhibitors block dengue and Zika virus replication. Antiviral Res. 2019;171. doi:10.1016/j.antiviral.2019.104590
  • Chen T, Mou Y, Tan J, et al. The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2015;25(1):55–64. doi:10.1016/j.intimp.2015.01.01125614226
  • ChoH Y, Imani F, Miller-DeGraff L, et al. Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease. Am J Respir Crit Care Med. 2009;179(2):138–150. doi:10.1164/rccm.200804-535OC18931336
  • Kesic MJ, Simmons SO, Bauer R, Jaspers I. Nrf 2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic Biol Med. 2011;51(2):444–453. doi:10.1016/j.freeradbiomed.2011.04.02721549835
  • Müller L, Meyer M, Bauer RN, et al. Effect of broccoli sprouts and live attenuated influenza virus on peripheral blood natural killer cells: A randomized, double-blind study. PLoS One. 2016;11:1. doi:10.1371/journal.pone.0147742
  • McElhaney JE, Gravenstein S, Upshaw CM, et al. Granzyme B: A marker of risk for influenza in institutionalized older adults. Vaccine. 2001;19(27):3744–3751. doi:10.1016/S0264-410X(01)00087-111395209
  • McElhaney JE, Ewen C, Zhou X, et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine. 2009;27(18):2418–2425. doi:10.1016/j.vaccine.2009.01.13619368783
  • Wu M, Gibbons JG, DeLoid GM, et al. Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol. 2017;313(1):L138–L153. doi:10.1152/ajplung.00075.201728408365
  • Bewley MA, Budd RC, Ryan E, et al. Opsonic phagocytosis in chronic obstructive pulmonary disease is enhanced by Nrf2 agonists. Am J Respir Crit Care Med. 2018;198(6):739–750. doi:10.1164/rccm.201705-0903OC29547002
  • Wise RA, Holbrook JT, Criner G, et al. Lack of effect of oral sulforaphane administration on Nrf2 expression in COPD: A randomized, double-blind, placebo controlled trial. PLoS One. 2016;11:11. doi:10.1371/journal.pone.0163716
  • Houghton CA. Sulforaphane: its “coming of age” as a clinically relevant nutraceutical in the prevention and treatment of chronic disease. Oxid Med Cell Longev. 2019;2019. doi:10.1155/2019/2716870.
  • Chen L, Lu Y, Zhao L, et al. Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs. Int Immunopharmacol. 2018;61(October2017):1–7. doi:doi:10.1016/j.intimp.2018.04.04129778842
  • LeeI C, Kim DY, Bae JS. Sulforaphane reduces HMGB1-mediated septic responses and improves survival rate in septic mice. Am J Chin Med. 2017;45(6):1253–1271. doi:10.1142/S0192415X1750069028830206
  • Xiao X, Yang M, Sun D, Sun S. Curcumin protects against sepsis-induced acute lung injury in rats. J Surg Res. 2012;176:1. doi:10.1016/j.jss.2011.11.103221704328
  • Gautret P, Lagier J-C, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949. doi:10.1016/j.ijantimicag.2020.105949.32205204
  • Min J-Y, Jang YJ. Macrolide therapy in respiratory viral infections. Mediators Inflamm. 2012;2012:649570. doi:doi:10.1155/2012/64957022719178
  • Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The immunomodulatory effects of macrolides a systematic review of the underlying mechanisms. Front Immunol. 2018;9:302. doi:10.3389/fimmu.2018.0030229593707
  • Iwayama K, Kusakabe A, Ohtsu K, et al. Long-term treatment of clarithromycin at a low concentration improves hydrogen peroxide-induced oxidant/antioxidant imbalance in human small airway epithelial cells by increasing Nrf2 mRNA expression. BMC Pharmacol Toxicol. 2017;18(1):15. doi:10.1186/s40360-017-0119-828235416
  • Yang Y, Cuevas S, Armando I, Jose P. Azithromycin induces sestrin2 expression through Nrf2 signaling pathway in lung epithelial cells stimulated with cigarette smoke extract (869.11). FASEB J. 2014;28(1_supplement):869.11. doi:10.1096/fasebj.28.1_supplement.869.11
  • Conforti C, Giuffrida R, Zalaudek I, DiMeo N. Doxycycline, a widely used antibiotic in dermatology with a possible anti‐inflammatory action against IL ‐6 in COVID ‐19 outbreak. Dermatol Ther. 2020. doi:10.1111/dth.13437
  • Kuang X, Scofield VL, Yan M, Stoica G, Liu N, Wong PKY. Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice. Brain Res. 2009;1286:174–184. doi:10.1016/j.brainres.2009.06.00719523933
  • Clemens DL, Duryee MJ, Sarmiento C, et al. Novel antioxidant properties of doxycycline. Int J Mol Sci. 2018;19:12. doi:10.3390/ijms19124078
  • Sun Z, Niu Z, Wu S, Shan S. Protective mechanism of sulforaphane in Nrf2 and anti-lung injury in ARDS rabbits. Exp Ther Med. 2018;15(6):4911–4915. doi:10.3892/etm.2018.603629805514
  • Takahashi E, IndalaoI L, Sawabuchi T, et al. Clarithromycin suppresses induction of monocyte chemoattractant protein-1 and matrix metalloproteinase-9 and improves pathological changes in the lungs and heart of mice infected with influenza A virus. Comp Immunol Microbiol Infect Dis. 2018;56:6–13. doi:10.1016/j.cimid.2017.11.00229406285
  • Qi T, Xu F, Yan X, Li S, Li H. Sulforaphane exerts anti-inflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2/ARE pathway. Int J Mol Med. 2016;37(1):182–188. doi:10.3892/ijmm.2015.239626531002
  • Kumari A, Singh DK, Dash D, Singh R. Intranasal curcumin protects against LPS-induced airway remodeling by modulating toll-like receptor-4 (TLR-4) and matrixmetalloproteinase-9 (MMP-9) expression via affecting MAP kinases in mouse model. Inflammopharmacology. 2019;27(4):731–748. doi:10.1007/s10787-018-0544-330470954
  • Li Q, Zhou X, Yu H, Nie X, Xu X. Regulation of neutrophil elastase-induced muc5ac expression by nuclear factor erythroid-2 related factor 2 in human airway epithelial cells. J Investig Med. 2010;58(5):730–736. doi:10.231/JIM.0b013e3181d88fde
  • Inoue D, Kubo H, Sasaki T, et al. Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14. Respirology. 2008;13(2):215–220. doi:10.1111/j.1440-1843.2007.01227.x18339018
  • Zingg J-M, Nakagawa K, Azzi A, Meydani M. Modulation of CD36 scavenger receptor expression by curcumin and vitamin E affects cellular uptake of lipids and bacteria (639.1). FASEB J. 2014;28(1_supplement):639.1. doi:10.1096/fasebj.28.1_supplement.639.1
  • Harvey CJ, Thimmulappa RK, Sethi S, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med. 2011;3(78):78ra32. doi:10.1126/scitranslmed.3002042
  • Ishimatsu Y, Harada T, Hara A, et al. The preventive effect of macrolide antibiotics on postinfluenza bacterial pneumonia in COPD model mice. In: C60. TRANSLATIONAL AND BASIC INVESTIGATIONS IN PULMONARY INFECTION. American Thoracic Society International Conference Abstracts American Thoracic Society; 2018:A5479–A5479. doi:10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A5479
  • Simonis FD, deIudicibus G, Cremer OL, et al. Macrolide therapy is associated with reduced mortality in acute respiratory distress syndrome (ARDS) patients. Ann Transl Med. 2018;6(2):24. doi:10.21037/atm.2017.12.2529430441